Adiponectin levels decrease independently of body mass index and diabetes type after the normalization of...

Area of Science:

• Endocrinology
• Metabolic Disorders
• Emergency Medicine

Background:

• Acute hyperglycemia is a common emergency department (ED) presentation, often a complication of diabetes mellitus (DM).
• Adiponectin, an adipokine, plays a role in glucose and lipid metabolism.
• Changes in adiponectin levels during acute hyperglycemia and its treatment are not fully understood.

Purpose of the Study:

• To investigate the alterations in serum adiponectin levels in patients experiencing acute hyperglycemia.
• To determine the effect of insulin treatment and blood glucose normalization on adiponectin levels in an emergency setting.

Main Methods:

• A cohort of 48 adult patients admitted to the ED with acute hyperglycemia was studied.
• Serum adiponectin levels were measured upon admission and 6 hours post-normalization of blood glucose with insulin.
• Statistical analysis was performed to assess changes in adiponectin levels.

Main Results:

• Serum adiponectin levels significantly decreased after blood glucose normalization in all patients.
• Adiponectin levels dropped from a median of 28.9 ± 16.5 μg/mL to 12.1 ± 10.9 μg/mL (P < 0.0001).
• This reduction in adiponectin was observed irrespective of diabetes type or body mass index.

Conclusions:

• Blood glucose normalization in hyperglycemic patients leads to a significant decrease in adiponectin levels.
• The observed decrease in adiponectin is independent of diabetes type and body weight.
• Potential mechanisms include inhibited adiponectin secretion or blunted insulin effects during hyperglycemia or insulin therapy.